Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best affordable stocks to buy under $20. Teva ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’s Substack by Kontra. In this ...

The once-a-month extended-release injectable suspension incorporates Medincell's copolymer technology. Credit: ...

Teva Pharmaceuticals and Medincell recently announced that the FDA has approved UZEDY® (risperidone), a once-monthly ...

After a two-year testing period and numerous trials, Teva successfully validated the global transportation of ...

TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its third quarter 2025 financial ...

Viatris' dividend yield is 4.93%, while Teva hasn't paid dividends since 2017. Thus, summing up this information, Viatris is ...

Teva Pharmaceutical Industries (NYSE:TEVA) just landed U.S. FDA approval for UZEDY, an extended-release injectable developed ...

Sound Shore Management, an investment management firm, has released its investor letter for the fourth quarter of 2024. A ...

Teva and Prestige announce a license and supply agreement for the commercialization of Prestige’s Tuznue ® , a biosimilar to Herceptin ® ...